Open Label Study Assessing Effectiveness Of Amlodipine/Atorvastatin In Subjects With Hypertension and Dyslipidaemia

NCT00330785 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1250

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension
Dyslipidemia

Interventions

DRUG: Amlodipine/Atorvastatin

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.